Goodman Advisory Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-600
| Closed | -$24.1K | – | 159 |
|
|
2025
Q1 | $24.1K | Buy |
+600
| New | +$24.1K | 0.01% | 127 |
|
|
2024
Q4 | – | Sell |
-600
| Closed | -$31.7K | – | 83 |
|
|
2024
Q3 | $31.7K | Hold |
600
| – | – | 0.01% | 130 |
|
|
2024
Q2 | $32.5K | Hold |
600
| – | – | 0.01% | 122 |
|
|
2024
Q1 | $42.1K | Hold |
600
| – | – | 0.01% | 101 |
|
|
2023
Q4 | $50.1K | Hold |
600
| – | – | 0.02% | 95 |
|
|
2023
Q3 | $17.7K | Hold |
600
| – | – | 0.01% | 116 |
|
|
2023
Q2 | $19.6K | Hold |
600
| – | – | 0.01% | 106 |
|
|
2023
Q1 | $21.1K | Hold |
600
| – | – | 0.01% | 96 |
|
|
2022
Q4 | $27K | Hold |
600
| – | – | 0.02% | 89 |
|
|
2022
Q3 | $29K | Hold |
600
| – | – | 0.02% | 88 |
|
|
2022
Q2 | $24K | Buy |
+600
| New | +$24K | 0.01% | 93 |
|